Ranok Therapeutics is based in Hangzhou, China. It has raised $50M in total funding. Latest round: Series B.
Ranok Therapeutics is based in Hangzhou, China. Ranok Therapeutics has raised $50M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in August 2021. The round record for Ranok Therapeutics runs through 2021; nothing later has been disclosed. Investors on record include Lapam Capital, Shanghai Healthcare Capital, Wu Capital, Zhongguancun Kaiyuan Capital, Med-Find Capital, LC Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
We update the Ranok Therapeutics record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Hangzhou and their backers are listed below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026